Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Shiji Biotechnology

Explore full profile

SciGene produces and markets automated instruments for genomic research labs, reducing expenses and improving result accuracy

Sunnyvale, United StatesFounded 2003Biotech & Life Sciences
Valuation $500M–1B Last recorded · 2024
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Shiji Biotechnology and the history behind them.

About Shiji Biotechnology

SciGene specializes in automating workflows for cytogenetic laboratories, focusing on reducing costs and enhancing the reliability of assay results. The company operates in the cytogenetics market, serving laboratories that require precise and efficient preparation of chromosome slides for various analyses such as G banding and FISH (Fluorescence In Situ Hybridization). SciGene's core products include the Scorpion Slide Preparation Robot and the Little Dipper Processor, which automate the preparation and banding of slides, respectively. These products are designed to improve the efficiency and accuracy of cytogenetic assays by automating time-consuming manual processes. SciGene's business model revolves around selling these specialized robotic systems and related consumables, such as CytoDrop Slides, which are engineered to provide uniformly wettable surfaces for optimal sample spreading. The company generates revenue through the sale of these products and potentially through service agreements for maintenance and support. SciGene's clients are primarily clinical and research laboratories that require high-quality cytogenetic analysis with fast turnaround times. The company's market includes both domestic and international laboratories that perform karyotyping and other chromosome analyses.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2003
Headquarters
Sunnyvale, United States
Employees
1
Open positions
None listed
Dealroom signal
23.0/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
b2b

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SECONDARYOther financing Feb 2024 $227M $756M Tongwei Group ↗
LATE VCOther financing Sep 2023 $55M $275M CICC · Anhui State Control ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Shiji Biotechnology website traffic

Latest recorded traffic for Shiji Biotechnology is 2.5K monthly website visits, up 38.9% over the last three months. Shiji Biotechnology's team grew 0% over the past year.

Latest monthly visits2.5K 3-month web change+38.9% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Amygdala NeuroscienceAmygdala's mission is to address the growing unmet need associated with substance use disorder by discovering, developing and commercializing safe and effective pharmacotherapies to treat and prevent addiction Palo Alto, United States Operational 3 $7.6M —
Beckley PsytechClinical-stage biotechnology developing rapid-acting psychedelic medicines Beckley and Stowood, United Kingdom Operational
Nucleome TherapeuticsDecoding the dark matter of the human genome to discover first-in-class precision medicine Oxford, United Kingdom Operational
Rosa BiotechAI-driven biosensing and diagnostics company providing outcome-focused biosensing for early disease diagnosis and for use in industrial biotechnology Bristol, United Kingdom Operational
EmpiricoHuge biological datasets, human genetics, and programmable biology to power novel target discovery and development San Diego, United States Operational
BraeburnBraeburn is dedicated to delivering solutions for people living with the serious, often fatal consequences of opioid addiction Washington DC, United States Operational
PredxBioTissue-Based Decision Intelligence for Oncology Bellevue, United States Operational
BiofourmisBiotechnology company that augments personalized care and therapies using digital therapeutics Boston, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later3 investors entered at this stage

  • CICC
  • Anhui State Control
  • Tongwei Group
Employees 1 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Shiji Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shiji Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.